| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Mitogen-activated protein kinase 11 |
|---|
| Ligand | BDBM50401152 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_881229 (CHEMBL2211534) |
|---|
| IC50 | <10000±n/a nM |
|---|
| Citation |  Sunose, M; Bell, K; Ellard, K; Bergamini, G; Neubauer, G; Werner, T; Ramsden, N Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease. Bioorg Med Chem Lett22:4613-8 (2012) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Mitogen-activated protein kinase 11 |
|---|
| Name: | Mitogen-activated protein kinase 11 |
|---|
| Synonyms: | MAP kinase p38 | MAPK11 | MK11_HUMAN | Mitogen-activated protein kinase 11 | Mitogen-activated protein kinase p38 beta | PRKM11 | SAPK2 | SAPK2B | Stress-activated protein kinase 2 | p38 MAP kinase alpha/beta | p38-2 | p38-beta | p38b |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 41351.73 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | gi_20128774 |
|---|
| Residue: | 364 |
|---|
| Sequence: | MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQ
SLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ
ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVG
TPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAA
EALAHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWKELTYQEVLSFKPPEPPKPPGSL
EIEQ
|
|
|
|---|
| BDBM50401152 |
|---|
| n/a |
|---|
| Name | BDBM50401152 |
|---|
| Synonyms: | CHEMBL2205766 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C15H18N6O2S |
|---|
| Mol. Mass. | 346.407 |
|---|
| SMILES | CC(C)(C)NS(=O)(=O)c1cncc(c1)-c1ccn2nc(N)nc2c1 |
|---|
| Structure | 
|
|---|
Search and Browse
